news    views    podcast    learn    |    about    contribute     republish    
Share this article: facebook . twitter . linkedin . reddit

Accuray launches new TomoHDA and gets FDA okay for CyberKnife M6

November 1, 2012

New TomoTherapy System enables faster planning and more focused delivery often resulting in half beam-on time than previously.

CyberKnife M6 (shown above) is a 3D image-guided and robotically controlled beam and patient positioning radiology delivery system.
Accuray stock (ARAY:NASDAQ) is up 64% year-to-date from $2.72 to $6.95.

Frank Tobe
guest author
Frank Tobe is the owner and publisher of The Robot Report, and is also a panel member for Robohub's Robotics by Invitation series.


comments powered by Disqus


Listening like a Human, Playing like a Machine
January 10, 2020

Are you planning to crowdfund your robot startup?

Need help spreading the word?

Join the Robohub crowdfunding page and increase the visibility of your campaign